← Research library

Study of delta sleep-inducing peptide efficacy in improving sleep on short-term administration to chronic insomniacs.

Controlled study in people · 1987

What was studied
Patients with chronic insomnia; double-blind crossover
Main finding
A double-blind crossover study found little clinically significant sleep improvement with DSIP; some nominal sleep-stage differences were already present at baseline.

Reported findings and study design

A double-blind crossover study found little clinically significant sleep improvement with DSIP; some nominal sleep-stage differences were already present at baseline.

Insomnia patients studied over four nights with polysomnography; sample size not stated in the abstract.

Population or model Patients with chronic insomnia; double-blind crossover

Results · Primary-publication indexed abstract; no full-text table appraisal
MeasureResultComparison, timing and statistics
Awakenings and wake timeDecreased during DSIP, without significant baseline or placebo differencesAlso applies to NREM latency and waking after sleep onset
NREM and stage 2 sleepNominal differences versus placebo, with the same differences already present at baseline
Slow-wave and REM sleepNot modified
Studied exposure25 nmol/kg intravenously; four-night crossover

The abstract contains no sleep-duration effect sizes or arm-level counts. Its conclusion is limited clinical significance.

Source for these results ↗ · Reviewed 2026-11-01

Study limitations and source details

Study limitations

  • Baseline differences complicate interpretation; sample size is not provided in the indexed abstract.

Source details

Indexed metadata and abstract checked via PubMed / Europe PMC; full methods and risk-of-bias assessment pending.

Sources checked

Citation

Clinical trial / comparisonEnglish abstract

Monti JM, Debellis J, Alterwain P, Pellejero T, Monti D. Study of delta sleep-inducing peptide efficacy in improving sleep on short-term administration to chronic insomniacs. International journal of clinical pharmacology research 7(2):105-110

Study source ↗ · Bibliography entry · Link to this summary

Related compounds

Editorial policy and evidence standards